By Gareth John Macdonald – Genetic Engineering & Biotechnology News
High production costs are limiting patient access to cell and gene therapies, according to researchers who say optimizing manufacturing methods and increasing capacity industry-wide would help. Cell and gene therapies are expensive. Analysis by the Institute for Clinical and Economic Review (ICER) suggests the average cost of a gene therapy is between $1 million and $2 million per dose.
Similarly, while cell therapy prices differ more widely depending on the indication and the type of product, the average cost per treatment is $1 million, according to the ICER.